14-50112618-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024558.3(VCPKMT):āc.672A>Cā(p.Lys224Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000419 in 1,529,108 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_024558.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VCPKMT | NM_024558.3 | c.672A>C | p.Lys224Asn | missense_variant | 5/6 | ENST00000395860.7 | NP_078834.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VCPKMT | ENST00000395860.7 | c.672A>C | p.Lys224Asn | missense_variant | 5/6 | 1 | NM_024558.3 | ENSP00000379201.2 |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 152140Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000625 AC: 11AN: 175992Hom.: 0 AF XY: 0.0000426 AC XY: 4AN XY: 93954
GnomAD4 exome AF: 0.0000203 AC: 28AN: 1376850Hom.: 0 Cov.: 24 AF XY: 0.0000235 AC XY: 16AN XY: 682244
GnomAD4 genome AF: 0.000236 AC: 36AN: 152258Hom.: 0 Cov.: 32 AF XY: 0.000255 AC XY: 19AN XY: 74468
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 23, 2024 | The c.672A>C (p.K224N) alteration is located in exon 5 (coding exon 5) of the VCPKMT gene. This alteration results from a A to C substitution at nucleotide position 672, causing the lysine (K) at amino acid position 224 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at